PRUDENTIAL FINANCIAL INC

Position in OCGN — Ocugen, Inc.

CIK 1137774 NEWARK, NJ

Position in OCGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$88,518

+$73,467 QoQ

Shares Held

57,855

+171.4% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#68

of 147 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. OCGN ranks #153 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	130,659	$81,471,112
2	VRTX	Vertex Pharmaceuticals Inc / Ma	133,294	$66,211,127
3	BMRN	Biomarin Pharmaceutical Inc	392,811	$22,476,644
4	INCY	Incyte Corp	191,312	$21,687,128
5	CYTK	Cytokinetics Inc	214,535	$18,276,236
6	LGND	Ligand Pharmaceuticals Inc	54,623	$17,265,784
7	PTCT	Ptc Therapeutics, Inc.	185,820	$15,157,337
8	MRVI	Maravai Lifesciences Holdings, Inc.	2,152,154	$13,429,440

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$88,518	57,855	+171.4%	Shares	Defined	2026-08-12
2025-03-31	$15,051	21,320	+9.3%	Shares	Defined	2025-05-13
2024-12-31	$15,705	19,510	-18.4%	Shares	Defined	2025-02-11
2024-09-30	$23,718	23,910	-46.0%	Shares	Defined	2024-11-14
2024-06-30	$68,680	44,310	+190.8%	Shares	Defined	2024-08-13
2023-03-31	$12,995	15,235	0.0%	Shares	Defined	2023-05-12
2022-12-31	$19,805	15,235	0.0%	Shares	Defined	2023-02-14
2022-09-30	$27,118	15,235	0.0%	Shares	Defined	2022-11-04
2022-06-30	$34,583	15,235	+8.7%	Shares	Defined	2022-08-15
2022-03-31	$46,249	14,015	0.0%	Shares	Defined	2022-05-13
2021-12-31	$63,768	14,015	-4.3%	Shares	Defined	2022-02-14
2021-09-30	$105,187	14,650	+1.4%	Shares	Defined	2021-11-15
2021-06-30	$116,033	14,450	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.